Quantcast

Latest biopharmaceutical Stories

2014-05-12 08:31:34

LYNBROOK, N.Y., May 12, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) in the U.S. and XIAPEX(®) in the EU, today announced that BioSpecifics' President, Tom Wegman, will present at the following upcoming investor conferences. -- 2014 UBS Global Healthcare Conference (New York, NY)Monday, May 19, 2014 at 9:30 a.m. EDT -- Jefferies 2014 Global...

2014-05-11 00:21:06

The NextGEN(TM) CRISPR genome engineering tools and services provided by Transposagen are ideal when research and drug discovery applications require clean, high-precision genome editing. LEXINGTON, Ky., May 11, 2014 /PRNewswire-iReach/ -- Altering the genome with targeted nucleases is powerful and increasingly necessary for research and drug discovery. The CRISPR-Cas9 system has gained popularity due to its simplicity and high efficiency. While the original CRISPR technology is not...

2014-05-09 08:26:09

CAMEO Phase 2 Clinical Trial of LUM001 Now Enrolling Adults with Primary Sclerosing Cholangitis SAN DIEGO, May 9, 2014 /PRNewswire/ -- Lumena Pharmaceuticals (Lumena), a biopharmaceutical company focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, today announced the dosing of the first patient in the INDIGO Phase 2 clinical trial of its lead drug candidate, LUM001, in children with progressive...

2014-05-09 08:25:32

BOSTON, May 9, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that its Chairman and CEO, Josef von Rickenbach, was named 2014 Immigrant Entrepreneur of the Year in Life Sciences by the Immigrant Learning Center of Malden, Mass. He received the award May 8, 2014, during the third annual Immigrant Entrepreneur Awards Dinner in Cambridge, Mass. A native of Switzerland, Mr. von Rickenbach earned a...

2014-05-07 08:32:51

LA JOLLA, Calif., May 7, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced the expansion of its Board of Directors with the appointment of two new members: -- Lynn D. Bleil, former leader of McKinsey & Company's West Coast Healthcare Practice and a leader of the worldwide Healthcare Practice --...

2014-05-07 08:32:47

MONROVIA, Calif., May 7, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will release first quarter financial results after market close on Wednesday, May 14, 2014. Xencor management will host a webcast and conference call the same day at 4:30 p.m. EDT (1:30 p.m. PDT) to discuss the financial...

2014-05-06 16:33:13

JUPITER, Fla., May 6, 2014 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today that they have strengthened their European leadership team with the addition of two senior level positions. (Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO...

2014-05-06 16:28:42

LONDON, May 6, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Cell Culture: The Market for Media, Sera and Reagents, 5th Edition http://www.reportbuyer.com/pharma_healthcare/diagnostics/cell_culture_market_media_sera_reagents_5th_edition.htmlThe growth in biopharmaceuticals is creating an unprecedented increase in demand for cell culture products. Cell culture techniques have been used in biological sciences for more than 50 years; however, cell culture...

2014-05-06 04:23:34

SEATTLE, May 6, 2014 /PRNewswire/ -- CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, have entered into an agreement to further develop the production process for transfer and clinical manufacturing of one of MacroGenics'...

2014-05-05 08:27:46

SANTA ROSA, Calif., May 5, 2014 /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN), a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the underwriters of Ruthigen's recently completed initial public offering have partially exercised their option to purchase additional shares of common stock. The underwriters have purchased an additional...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related